09:48 AM EST - Cipher Pharmaceuticals Inc. : announced its financial and operational results for the three months ended September 30, 2013. Net revenue increased to $5.6 million, from $2.1 million in Q3 2012. EBITDA was $3.6 million versus $1.0 million in Q3 2012. Net income was $3.4 million, or $0.14 per share, compared with net income of $0.08 million, or $0.03 per share, in Q3 2012. Cipher Pharmaceuticals Inc.
shares T.DND are trading up $0.76 at $8.20.
